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E-mail address: mmann@biochem.mpg.de (M. ManProteomics has made tremendous progress, attaining throughput and comprehensiveness so far
only seen in genomics technologies. The consequent avalanche of proteome level data poses great
analytical challenges for downstream interpretation. We review bioinformatic analysis of qualita-
tive and quantitative proteomic data, focusing on current and emerging paradigms employed for
functional analysis, data mining and knowledge discovery from high resolution quantitative mass
spectrometric data. Many bioinformatics tools developed for microarrays can be reused in proteo-
mics, however, the uniquely quantitative nature of proteomics data also offers entirely novel anal-
ysis possibilities, which directly suggest and illuminate biological mechanisms.
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Biological systems function via intricately orchestrated cellular
processes in which various cellular entities – RNAs, metabolites
and proteins participate in a tightly regulated manner. Proteins
are at the ‘executive core’ of these cellular events, and their altered
behaviors have been implicated in myriad disease pathologies,
which also makes them by far the major class of drug targets.
Therefore, understanding the structure, dynamics and interactions
of proteins has been at the heart of biomedical research from its
very inception. Due to limitations of biochemical methods and al-
lied technologies, such studies have traditionally been carried out
on single proteins, rather than the entire population of expressed
proteins in a cell or tissue, the ‘proteome’ [1]. The discipline of pro-
teomics was initially equated with two-dimensional gel electro-
phoresis, a low resolution technology that can only analyze the
most abundant proteins in a sample. In recent years mass spec-
trometry (MS) has become a powerful technology to study proteins
on a large-scale [2,3]. Combined with innovative experimental
strategies [4], and advances in computational methods [5,6], MS-
based proteomics now enables global study of cellular proteomes.
This relatively novel development has led to a surge of qualita-
tive and quantitative data at the proteome level, which has posed
analytical challenges hitherto unseen by protein researchers. The
mapping of complex proteomics data to biological processes has
become impossible by manual means, and the need for com-chemical Societies. Published by E
n).puter-aided data analysis is essential for further progress of the
ﬁeld. Proteomics is today at the same crossroads that genomics
was at a decade ago in terms of tackling these challenges. Bioinfor-
matics, the scientiﬁc ﬁeld dealing with analyzing large numbers of
genes or their transcripts, in fact emerged largely from that chal-
lenge [7]. It has evolved to deal with a multitude of different bio-
logical data types and should now be well-equipped to aid
proteomics [8]. Indeed, proteomics researchers are already actively
collaborating with bioinformaticians for comprehensive functional
analysis and systematic knowledge mining of complex data sets.
We subscribe to the deﬁnition of bioinformatics as a mean for
functional analysis and data mining of data sets leading to biolog-
ically interpretable results and insights. In this review we highlight
recent advances, results, and challenges in proteome based bioin-
formatics research. Thus the scope of our review is downstream
of the related and partially overlapping ﬁeld of ‘computational pro-
teomics’ which blends mathematical, computational and statistical
algorithms to address key problems related to protein identiﬁca-
tion and quantitation from raw mass spectrometry data.
2. Bioinformatics for qualitative proteomics
Until a few years ago proteomics was largely a qualitative disci-
pline. The proteomic experiment typically consisted in identifying
as many proteins as possible in a protein complex, organelle or cell
or tissue lysate. In the course of obtaining the protein identities of
any protein mixture, an enzymatic digestion step is usually em-
ployed, yielding a large collection of proteolytic peptides that are
then analyzed by ‘shotgun’ proteomics [9]. This is illustrated inlsevier B.V. All rights reserved.
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normal peptides or peptides bearing post-translational modiﬁca-
tions such as phosphorylation, has been bioinformatically analyzed
for various purposes as symbolized by the left part of the ﬁgure.
The focus of qualitative proteomics was on the correctness and
the depth of analysis but the result of the experiment was typically
simply a list of proteins. As proteome catalogs started getting lar-
ger, they were nevertheless unyielding to manual analysis due to
the sheer numbers of proteins, and the immediate challenge was
to obtain biological insights into the system being studied (right
part of Fig. 1).
The peptides created and collated in shotgun proteomics pro-
jects are not functional biological entities and they are therefore
usually only of interest for the technology of proteomics itself.
Nevertheless, they can be mined for physiochemical and amino
acid residue patterns using machine learning approaches, which
form the basis for various classiﬁcation and prediction routines.
This can be useful, for example, in predicting which peptides are
likely to be detected in proteomics experiments and which are un-
ique for the parent protein – so called proteotypic peptides [10,11].
These peptides can then be speciﬁcally targeted by specialized
mass spectrometric techniques such as multiple reaction monitor-
ing (MRM) during an analysis in which one is only interested in
monitoring the levels of selected proteins [12]. The ‘PeptideAtlas’
has been created for this purpose and extracts proteotypic peptides
and their associated fragmentation spectra from a large number of
submitted proteomic data sets [13].
Peptides sequenced in proteomics projects can be mapped onto
the positions in the genome that code for them. In this way the
peptides provide evidence that the gene is actually expressed
and is not, for example, a pseudogene. This is important because
a large fraction of the predicted genes in the genomes of eukary-Fig. 1. Bioinformatics analysis paths for qualitative proteomics. The peptide inventory i
machine learning approaches–such as proteotypic peptides. The identiﬁed peptides can
genome annotations. Post translationally modiﬁed (PTM) peptides such as phosphope
directions after the peptide identiﬁcations are consolidated into protein identiﬁcations.
sampling and identiﬁcation biases towards acidic or basic proteins or high molecular we
integrated with annotational databases like Gene Ontology and PFAM to ﬁnd enriched bio
these proteins can be mapped to network and pathway databases (STRING, KEGG) to viotes do not yet have any direct experimental protein information
associated with them. Peptide atlases have been used to ﬁnd novel
transcripts, and to reﬁne gene models, in principle leading to aug-
mented genome and proteome annotations [14,15]. A new sub-dis-
cipline of bioinformatics called ‘comparative proteogenomics’ has
now emerged from such endeavors, which proposes to harness
MS-based proteomics data sets in conjunction with DNA sequence
data sets for large-scale genome and proteome annotation [16]. So
far efforts in this area have mined large-scale and usually low res-
olution data. However, in our opinion, genome annotation should
only be done with very high accuracy data that has extremely
low error rates. Such data can now readily be produced by the last
generation of high precision mass spectrometers [3].
Additionally, the peptide identiﬁcation information can serve as
a very rough indication of protein quantity in the sample. The basic
idea is that the abundance of each protein scales with the number
of identiﬁed peptides. One approach, termed peptide or spectral
counting uses the number of times that peptides belonging to a
protein are fragmented as a proxy for its abundance [17,18].
Kislinger et al. elucidated the proteome of six mouse tissues in this
way, followed by bioinformatics analysis of tissue speciﬁc prote-
ome function and regulation [19]. In a related approach, Ishihama
et al. showed that the absolute amount of protein in the sample
studied correlates with the exponential of the Protein Abundance
Index (peptides observed by MS divided by peptides that are
potentially observable) [20]. In a more advanced approach Lu
et al. used the peptide sampling information in a Bayesian frame-
work to deﬁne absolute protein expression measurements (APEX).
This measure provided an estimate of the relative contributions of
transcriptional and translational-level gene regulation in yeast and
Escherichia coli [21]. Nevertheless, these semi-quantitative ap-
proaches are falling out of favor because modern, high resolutiondentiﬁed by ‘shotgun proteomics’, (left part of ﬁgure) can be mined for patterns by
be mapped to genomic coordinates for identifying novel ORFs and for augmenting
ptides can be analyzed for sequence motifs. The right hand side shows analysis
The proteins can be examined for their physiochemical properties to uncover MS
ight proteins in a sample, for example. On the functional level these proteins can be
logical processes, functions, cellular components and protein domains. Additionally
sualize them in their modular functional contexts.
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experiments, in so called ‘label-free’ and much more accurate
quantitative proteomics (see below).
Mass spectrometry is especially well suited to analyze post-
translational modiﬁcations (PTMs) on peptides. In contrast to
unmodiﬁed peptides, these PTM-bearing peptides are of great bio-
logical interest because they reveal sites of functional changes to a
protein. Large-scale studies of phosphorylation, ubiquitination,
acetylation and many other PTMs are now possible, especially if
the modiﬁed peptides can be speciﬁcally enriched with respect
to unmodiﬁed ones [22–24]. In phosphorylation studies, the site
speciﬁc information is used to extract enriched sequence motifs,
which in turn provides insights into proteome regulation by up-
steam kinases, modular protein domain mediated interactions,
and also a basis for prediction of novel PTM sites [25–27]. Recently,
an approach called NetworKIN was reported that mines large-scale
phosphorylation data sets in the context of the protein–protein
interaction network topology to predict kinase substrates in phos-
phorylation networks [28]. The analysis of PTMs by mass spec-
trometry – especially in a quantitative format as described below
– is increasing exponentially and will be one of the main contribu-
tions of MS-based proteomics to biology.
Several types of bioinformatic analyses are almost invariably
performed on a measured proteome. Analyzing proteins for se-
quence features like transmembrane domains and signal peptides
can provide clues about features of studied sample – for instance
in cases where the membrane proteome is enriched, or where
one needs to determine the fraction of secreted proteins [29]. This
also helps in ascertaining and correcting experimental or MS-iden-
tiﬁcation related sampling biases in proteome catalogs [30]. For
example, Shi et al. used a kernel density based approach to corre-
late the isoelectric point (pI) and molecular weight feature space of
an MS-based mouse liver proteome to show that it was much more
unbiased than earlier 2D-gel based studies, and was largely repre-
sentative of complete mouse proteome (with Pearson correlation
of 0.98) [31]. The same approach was subsequently applied to
compare in-gel digestion and isoelectric focusing separation meth-
ods in a study of a Drosophila cell line [32].
On the level of protein catalogs, the bioinformatics analysis typ-
ically involves integration of proteome data with annotational dat-
abases, such as Gene Ontology (GO) [33], protein domains
(InterPro, PFAM) [34] and pathway database (KEGG) [35] – to
determine if any of these properties are over or underrepresented.
This type of analysis may directly yield functional insights into the
data set and is easily accomplished using standard tools. DAVID
[36], GoMiner [37], Cytoscape [38] plug-ins like BINGO [39] are
examples of readily available software that can be used. In our lab-
oratory, we typically employ Bioconductor [40] within the R statis-
tical platform [41]. This requires some more programming
experience but offers broader capabilities and ﬂexibility in
analysis.
Adachi et al. studied the proteome of 3T3-L1 adipocytes and
performed advanced bioinformatic mining of a qualitative data
set [42]. The proteome was ﬁrst mapped to GO, KEGG and InterPro
databases, providing insights into adipocyte biology and functions.
Statistical enrichment tests were performed to ﬁnd signiﬁcant
over-represented GO and InterPro categories, which in turn related
to signal transduction, redox system, protein transport, translation,
transcription, protein degradation, fatty acid synthesis, and
phospholipid biosynthesis; all characteristic functions of adipo-
cytes. Putative biological functions were assigned to more than
50% of un-annotated proteins identiﬁed in 3T3-L1 cells through se-
quence similarity based annotation transfer [43]. Additionally, a
novel tool for functional association of proteins to protein-models
prototypical of the function of interest (insulin mediated vesicular
trafﬁc in this case) was employed [44]. This led to the associationof several proteins in the adipocyte proteome with this function,
at least one of which was later independently validated [45].
Combining proteomic data sets with complementary ‘omics’
data sets such as transcriptome data can reveal interesting facets
of cellular functions. In an early example, Mootha et al. compared
the mitochondrial proteome with tissue microarray data to show
that for mitochondrial proteins on a bulk level mRNA expression
levels are correlated with protein detection and their abundances.
Exploiting the much more readily available microarray data sets,
they also found that mitochondrial proteins show tissue speciﬁc
patterns of expression and regulation to a much greater extent
than previously recognized [46]. Furthermore, they characterized
key transcriptional regulators of mitochondria organelle biogenesis
using expression neighborhood analysis, which identiﬁed these
proteins by the co-regulation of their messages with the messages
corresponding to the mitochondrial proteome.
In a mouse liver organellar proteome study Foster et al. used
regulatory motif analysis to elucidate key players mediating orga-
nelle biogenesis [47]. Calvo et al. integrated protein identiﬁcation
information in mitochondria along with a collection of functional
genomics data sets in a naive Bayesian method to predict novel
mitochondrial candidates in humans [48]. Recently, Pagliarini
et al. used tissue wide mitochondrial proteome data from mouse
as an input for phylogenetic proﬁling across 42 eukaryotic species
and identiﬁed 19 new candidates of respiratory chain complex I
(CI). One of them C8orf38was directly implicated in a lethal CI deﬁ-
ciency [49]. Graumann et al. for the ﬁrst time compared the mouse
embryonic stem cell (mESC) proteome with a genome wide chro-
matin state map of mESC to show near perfect correlation between
protein expression and the presence of active rather than repres-
sive chromatin marks [50]. Mapping proteome data to pathway
databases like KEGG and network databases like STRING [51],
MINT/IntAct [52] and HPRD [53] can provide valuable clues about
the presence of signaling pathways and functionally interacting
modules of interest.3. The nature of quantitative proteomics data
Functional insight most often requires quantitative comparison
between two or more biological states. In the last few years proteo-
mics has been catapulted into the realm of high-throughput ‘omics’
technologies mainly due to signiﬁcant advances in two aspects,
ﬁrst the development of accurate methods of proteome-wide
quantitation, and second the development of computational pro-
teomics algorithms and software for efﬁciently harnessing this
quantitative proteomic data.
While mass spectrometry is not inherently quantitative, this
limitation has been successfully overcome by introduction of sta-
ble isotopes into the molecules to be identiﬁed. Stable isotope
labeling has been done for decades in small molecule MS and can
be performed in proteomics either by chemical modiﬁcation of
peptides after tryptic digestion or by metabolic labeling of intact
proteins during cell culture [54]. For example, iTRAQ is a com-
monly used technique in quantitative proteomics in which amino
groups of peptides (lysine side chain and the N-terminus) are
chemically labeled by isotopically different forms of the derivatiz-
ing agent. The most widespread metabolic labeling technique is SI-
LAC (stable isotope labeling by amino acids in cell culture) [55,56].
As the name indicates, SILAC incorporates the heavy labeled amino
acid into the entire proteome in the course of normal cell metabo-
lism and proliferation. SILAC therefore does not require any chem-
ical derivatization. It is generally considered the most accurate
quantitation strategy because all peptides of a protein are labeled
and because processing of proteins occurs after samples have al-
ready been combined and therefore cannot contribute to any quan-
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comprehensive quantitation of the yeast proteome [57], and now
facilitates routine measurement of expression changes of 4000–
6000 proteins in more complex eukaryotic cells [32,50].
Alternatively, protein quantiﬁcation without the use of isotopic
labels is emerging as a practical approach in MS-based proteomics.
This ‘label-free quantitation’ is especially important where isotope
labeling is not feasible or scalable, for example in many instances
in which tissues or clinical samples are measured. A precursor of
quantitative proteomics for patient samples is the SELDI method,
in which a low resolution MALDI spectrum is taken to be indicative
of the state of the proteome [58]. However, despite an extensive
literature on patient classiﬁcation using these patterns, the accu-
racy of such results and of the underlying data have been ques-
tioned [59,60]. In contrast, high resolution instruments are now
making it possible to directly compare the integrated peptide ion
signals between experiments. With the inclusion of sophisticated
MS data (signal) processing algorithms and advanced statistical
procedures accurate label-free proteomics appears to become fea-
sible, which may herald the beginning of successful clinical and
in vivo tissue proteomics endeavors.
Modern proteomic experiments generate gigabytes of data for a
typical experiment. While advanced algorithms for protein identiﬁ-Fig. 2. Quantitative data generation in MS based proteomics. Contemporary mass spect
instrumentation and computational proteomics platforms to generate high dimensional
SILAC) (left side of the ﬁgure) which typically are used in following temporal trajectories
across two or more levels. Proteomes that were not isotopically labeled (right side of th
Computational software such as MaxQuant enables parallel processing of these comple
information on peptide and protein identity, PTMs and their quantitative ratios.cations have been in vogue for nearly a decade [61,62], robust algo-
rithms for extracting protein quantitation information from the
multidimensional MS data structures have only recently started
to emerge. Retrieving protein identiﬁcation and quantitation from
MS data is an intensivemulti-level algorithmic endeavor, now stud-
ied in the above mentioned sub-discipline of ‘computational proteo-
mics’. It spans a gamut of computational, statistical and machine
learning algorithms especially applied or developed for peptide
and protein identiﬁcation and quantitation. In comparison to efforts
aimed at microarray data, the lack of standardized and comprehen-
sive quantitation software for MS data has been one of the major
challenges and bottleneck for proteomics. Empirical methods like
spectral counting have been employed for protein quantitation
(see above). Evenmethods that took the great complexity of proteo-
mics data [63] into account, were inherently of low accuracy be-
cause they were developed for low resolution MS data. Therefore,
they fail to deliver whenMS data is highly resolved and ﬁne grained
as generated by the latest generation of mass spectrometers. Our
laboratory has developed MaxQuant – a suite of integrated algo-
rithms speciﬁcally designed for high resolution, quantitative MS
data based on state-of-the-art data reduction, correlation analysis
and graph theory [6]. Mueller et al. recently reviewed other existing
computational proteomics frameworks and software [64].rometry based proteomics combines sophisticated experimentations, advanced MS
data sets. These data sets can come from either isotopic-labeled samples (such as
of cellular signaling events or in comparative proteomic phenotyping experiments
e ﬁgure) like tissue or clinical samples can be analyzed by a ‘label-free’ approach.
x data sets generating a multidimensional data matrix which contains a wealth of
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the very large size of MS data sets that can readily be generated to-
day. Complex experimental schemes need to be accommodated –
enabling parallel processing of samples generated by isotope-la-
beled and non-labeled proteomic experiments in replicates and
cross-over (isotope-swapping) experiments (Fig. 2). Accurate
quantitation, associated statistic, and quality control metrics need
to be generated and reported for thousands of proteins in each pro-
ject. One end product of such endeavors is a resultant matrix con-
taining expression values of thousands of proteins across many
conditions but also containing information pertaining to the pep-
tides identiﬁed, their uniqueness to the protein and so on. Such
matrices are much more complex than data structures generated
by microarrays, and pose at least as difﬁcult analysis and interpre-
tation challenges that accrue from their high dimensionality [65].
Furthermore, the wealth of proteomic information needs to be
mapped onto existing biological knowledge to generate new in-
sights. The general task for bioinformatics in this context is to pro-
vide the framework for systematic knowledge mining of such
proteomics data sets thereby mapping them back onto their bio-
logical context.
4. Bioinformatics for quantitative temporal, spatial, interaction,
phenotypic and proteomics
The technological ability of obtaining accurate global quantita-
tive proteome data by MS has infused new vigor into proteomic
studies in which cellular system trajectories are studied at the level
of proteome dynamics and post-translational modiﬁcations. Such
data sets are now regularly generated at different levels of cellular
function, organization and architecture and it is possible to sys-Fig. 3. Quantitative proteome analysis on multiple levels of cellular functions. Quan
perspectives of cellular organization. Typical questions that have now become feasible t
and proteome levels? (B) What are the phenotypic differences between a different bu
phosphorylated by an upstream kinase? (D) What is the distribution of protein populati
cellular condition? (E) What are the speciﬁc protein-protein interactions mediated by atematically investigate proteomes from various perspectives.
These include quantitative protein–mRNA expression correlation
and translational regulation effects on protein expression
(Fig. 3A), comparisons of the ‘proteomic phenotype’ across various
cellular or physiological states (Fig. 3B), temporal kinetics of pro-
teins and their post-translationally modiﬁed peptides (Fig. 3C),
spatial distribution of proteins across sub-cellular organelles
(Fig. 3D), and interaction partners of proteins mediating a pathway
or cellular process (Fig. 3E). Such diverse proteomic data sets have
in turn opened exciting vistas for their analysis by bioinformatics
and machine learning algorithms.
4.1. Quantitative gene-expression at message and protein levels
Quantitative mass spectrometry in principle provides similar
data than a microarray experiment; however, there are also impor-
tant differences. Due to technological challenges, quantitative pro-
teomic data sets have until recently been much smaller than
microarray data sets and they were often biased against low abun-
dance proteins. Nevertheless, proteomics has for some time been
able to obtain a relatively complete view of quantitative changes
in sub-proteomes such as organelles, for which there is no micro-
array equivalent. If the proteomics experiment is meant to provide
a quantitative map of the gene-expression differences between
two cellular states then it has the same goal as a microarray exper-
iment (or nowadays ‘deep RNA sequencing’ [66]) and in principle
the same bioinformatics tools can be used. Even in this case pro-
teomics may be closer to functional relevance because usually
mRNA is only an intermediate but not itself the active molecule
in the cell. This is true even when we consider regulatory mecha-
nisms such as those mediated by microRNAs, because their ulti-titative proteomics can now study cellular systems and functions from various
o answers include: (A) How does gene expression correlate quantitatively at mRNA
t related cell at the proteome level? (C) On a temporal scale how is a substrate
ons in organelles like mitochondria and nucleus versus the cytoplasm in any given
change in phosphorylation state of a protein?
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below, comprehensive quantitative proteomics has now become
possible and microarray and proteomics data sets can both be ana-
lyzed in a systems-wide manner.
Comparison of transcript and proteome level changes has been
a topic of immense interest since the days when microarrays and
proteomics technologies were still in their infancy [67,68]. These
early studies as well as recent ones using much more advanced
instrumentation have generally reported that at the global level
proteome and transcriptome exhibit poor correlation, while this
correlation is better for changes associated with a perturbation of
the system under study [32,57]. Quantitative proteomic data now
facilitate accurate assessment of transcriptome–proteome correla-
tion and helps in estimating the apparent level of technical and
stochastic noise in the respective data sets. In a recent proteome
wide study of haploid vs. diploid yeast Godoy et al. compared the
SILAC based protein ratios with mRNA expression and found that
for strongly regulated entities of the pheromone pathway the cor-
relation between protein and mRNAs was relatively high with cor-
relation coefﬁcient of 0.68 (Fig. 4A).
In a study of proteome changes upon dsRNA mediated knock-
down of the chromatin remodeling factor ISWI in Drosophila Bo-
naldi et al. showed that the quantiﬁed proteome covered a broad
spectrum of biological processes and functions. In terms of physio-
chemical properties (pI, molecular weight) these functions were
comparable to the complete Drosophila proteome ruling out bias
in MS-based identiﬁcation. This study again showed minimal cor-
relation for steady state levels of message and protein but en-
hanced correlation between regulated proteins and their
corresponding transcripts. When only considering robustly regu-
lated genes, the correlation coefﬁcient reached 0.8. Despite this
good correlation, the actually fold change of the proteins was not
predictable from microarray or RT-PCR data.
With the availability of high quality quantitative proteomic
data it is now feasible to move beyond the question of correlation
and explore differences in protein expression caused by transla-
tional regulation. In a recent study Selbach et al. studied global
protein expression changes induced by miRNA mediated gene
regulation for ﬁve distinct miRNAs in HeLa cells using ‘pulsed SI-
LAC’ [69]. Correlating protein expression as a function of miRNA
binding sites feature on the target mRNAs they found that protein
downregulation is strongly inﬂuenced by the presence of 30UTR
seed sequence motifs, and repression was more pronounced for
conserved seed sites. Moreover, they showed that only seed-con-
taining mRNAs (of the proteins proﬁled) with at least one mis-
match were overall repressed at the protein level, and
repression was more pronounced for conserved seed sites. Addi-
tionally, comparing protein expression with cognate transcript
expression showed that a multiplicity of a miRNA-binding site
in the same 30UTR exerts a stronger direct effect on protein pro-
duction than on mRNA levels. Another study on the same subject
found, in common with the Selbach et al. paper, that single miR-
NAs have a widespread but relatively mild effect on proteins tar-
gets [70].
4.2. Function from quantitative proteome comparisons
SILAC is a very potent and accurate technique for comparing rel-
ative proteome change where two or more phenotypic states need
to be compared, for instance before and after knock-down of a gene
of interest or to compare two related by divergent cell types. Typ-
ically, such studies provide relative proteome ratios for thousands
of proteins, and their goals are twofold – ﬁrst to enumerate global
properties of the quantiﬁed proteome, second and more impor-
tantly to access systems level differences in terms of biological
functions, regulation and pathway modules.Global comparisons of cellular systems and organisms have so
far been done on transcriptome, interactome and epigenome levels
[71–74]. Advanced quantitative proteomics adds a novel and very
pertinent dimension to these comparisons which should allow
molecular phenotypes to be discerned directly at the proteome le-
vel. Pan et al. measured the quantitative proteomic difference be-
tween Hepa1–6, a transformed hepatocyte cell line, and primary
hepatocytes from mouse by ‘proteomic phenotyping’ [75]. This ap-
proach combines the strength of high accuracy quantitation by SI-
LAC with a novel bioinformatics algorithm to provide a functional
portrait of signiﬁcant phenotypic differences (Fig. 4B). In this ﬁrst
proteome level comparison of a cell line vs. the corresponding pri-
mary cells more than 4000 proteins were quantiﬁed with high
accuracy and reproducibility (Pearson correlation across biological
replicates 0.95). Their quantitative distribution exhibited broad
spectrum of proteome changes (from 10 to +5 on log2 scale)
and was non-normally distributed with substantial negative skew.
Consequently, conventional methods of assigning up and downreg-
ulation would have failed because they implicitly assume an
underlying Gaussian distribution of fold changes. Instead, the com-
plete quantitative expression map was divided into ﬁve quantiles
of expressions and analyzed by bioinformatics for enriched KEGG
pathways, and GO biological process and cellular component of
each of the subpopulations. After consolidation and hierarchical
clustering of statistically signiﬁcant categories separately in KEGG
and GO a clear functional phenotype emerged, which provided
interesting insights into divergent and shared features of the two
cell types. For example, the result showed that Hepa1–6 cells were
deﬁcient in mitochondria, have lost many of the speciﬁc functions
typical of hepatocytes in vivo – for instance drug metabolizing en-
zymes (DMEs), complement production, and synthesis of extracel-
lular matrix. Conversely, the cell line shifts most of its resources
into functions associated with cellular proliferation, but maintains
important cell signaling pathways. This study and the associated
bioinformatics provides a good starting point as to which functions
can be studied in a the cell line and which are better studied in the
primary cells or in vivo. It also serves as a template for investiga-
tions of cellular phenotypes across various conditions.
4.3. Bioinformatics of temporal proteomics
Just as many microarray studies measure not only static differ-
ences between two cellular states but also the kinetics of a biolog-
ical process, proteomics can also directly measure kinetics. For
example, using the SILAC technology, three cellular states can be
isotopically labeled and be perturbed for three different time
points [76]. Repeating the experiment several times with a com-
mon reference point yields ﬁve point or higher kinetics. This
scheme was used to directly study the change in the nucleolar pro-
teome upon small molecule inhibition of the proteasome [77].
Functionally or physically interacting protein groups had similar
kinetics and the experiment supported the notion that the nucleo-
lus is not purely an activity based cellular structure dedicated to
transcribing rRNA genes.
White and co-workers have additionally linked temporal pro-
teomics to a matrix of downstream outcomes after epidermal
growth factor receptor (EGFR) activation [78]. They studied the
time course proﬁles of quantitative tyrosine phosphorylation
changes using iTRAQ, and the resultant temporal data for 78 sites
was clustered using self organizing map(SOM) thereby revealing
interesting modules in EGFR signaling network. In one of the ﬁrst
systems level phosphoproteomics study of in vivo signaling events,
Olsen et al. employed SILAC to generate quantitative time course
data of phosphoproteome changes across ﬁve time points after
EGF stimulation [79]. Apart from very high identiﬁcation conﬁ-
dence in the phosphopeptides, they provided statistical conﬁdence
Fig. 4. Exploring quantitative proteomics data using bioinformatics and machine learning. (A) Accurate quantitative proteomics enables gene expression comparison at
protein and mRNA levels thereby providing insights into translational and transcriptional regulations. In a global yeast proteomic study the quantitative proteomic ratios
correlated signiﬁcantly with the mRNAs for modulated entities of the pheromone pathway (middle part), while the global steady state correlation was minimal. The
quantitative proteome provided a systems wide view into the concomitant up regulation of pheromone signaling pathway components (bottom part). (B) ‘Proteomic
phenotyping’ provides a novel bioinformatics approach to functionally analyze the quantitative expression map emerging from proteomic comparison of primary cells and
cell line. (C) Time course proﬁles of phosphopeptides obtained after EGF stimulation were clustered using fuzzy c-means clustering to discern cluster patterns which were
mapped to representative biological functions. (D) In organellar proteomics of Arabidopsis the relative quantitative protein ratios across membrane fractions were analyzed
to assign novel proteins to various organelles of the endo-membrane system.
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phosphosite assignment. Analyzing the data for Gene Ontology
enrichment revealed that the majority of phosphorylation events
occur in the nucleus and cytoplasm, whereas mitochondria, for
example, are underrepresented. The data was furthered analyzed
using fuzzy c-means clustering to elucidate common patterns of
regulation. Key proteins with similar temporal proﬁles were auto-
matically grouped into clusters which turned out to form biologi-
cally relevant functional classes (Fig. 4C). The results of this
analysis were made available to biomedical community via a data-
base called PHOSIDA [27] which has since then matured into a
comprehensive data repository for phosphorylation related
information.
4.4. Bioinformatics of spatial proteomics
Mapping the sub-cellular localization of proteins is one of the
ﬁrst steps towards understanding their function in particular cellu-
lar contexts and is a prerequisite for systems-wide understanding
of the cell [80,81]. The task for organellar proteomics in particular
is to provide an inventory of the proteins making up the individual
organelles. Initially such studies were performed purely qualita-
tively, which may have been adequate when MS could only iden-
tify the major, puriﬁed components. However, with increasing
MS sensitivity minute contaminations are easily detected and con-
sequently there are no ‘pure’ organellar preparations anymore.
Therefore a quantitative dimension has become essential. Initial
quantitative organellar proteomics studies include the work of Fos-
ter et al. who used ‘protein correlation proﬁling’ (PCP) to determine
the integrated peptide intensity proﬁles for each protein across
sub-cellular fractions. Correlation with organelle speciﬁc marker
proteins led to the localization of more than 1,400 proteins to cyto-
solic organelles in mouse liver [47]. Through bioinformatic analysis
based on the concept of gene-expression neighborhood (basically
the Euclidian distance in gene expression space) they elucidated
key regulators of organelle biogenesis. Additionally, by compara-
tive genomics for cis-regulated, conserved elements they obtained
novel organelle speciﬁc enriched motifs–for instance binding mo-
tifs of Myc upstream of the genes encoding ER resident proteins.
In a technique termed Localization of Organelle Proteins by Isotope
Tagging (LOPIT), iTRAQ based relative quantitative protein ratios
are obtained across multiple sub-cellular fractions and analyzed
by multivariate data analysis algorithms. Dunkley et al. applied LO-
PIT to the Arabidopsis membrane proteome and determined the
relative quantitative protein ratios across membrane gradient frac-
tions by principal component analysis (PCA) and partial least
squares discriminant analysis (PLS-DA) (Fig. 4D) [82]. This analysis
assigned 527 proteins to organelles of endomembrane system and
also predicted novel candidates in Golgi apparatus, endoplasmic
reticulum, vacuolar and plasma membrane.
4.5. Bioinformatics of interaction proteomics
Cellular processes are generally carried out by stable or tran-
siently assembled protein complexes, therefore identiﬁcation of
protein-protein interaction (PPI) provides insights into cellular
dynamics and function. Recent advances in proteomics and allied
technologies have lead to a deluge of protein interaction data
and resulting interaction networks and databases [83]. They have
also spawned a ﬁeld of computational biology in which mathemat-
ical network analysis is applied to molecular and cell biology. One
of the key analytical directions in the PPI ﬁeld is understanding the
network behavior of these interactomes using concepts from ‘Net-
work Biology’ [84], and to gain insights into cellular organization
(as complexes or modules) and function by bioinformatics and ma-
chine learning methods [85,86]. A prominent question in all thesestudies is ascertaining the degree of true versus false interactions
(i.e. functionally valid vs. background interactions), which is a
key requirement for formulating biologically testable hypothesis
[87,88]. MS based quantitative proteomics is speciﬁcally suited
for providing highly accurate information of protein interactions
but only when it explicitly incorporates a quantitative dimension
[89]. The quantitative ratios are used not to determine the strength
of interaction but to discriminate background binders from speciﬁc
binders. This dimension has yet to be incorporated into bioinfor-
matics modeling of interaction networks.
MS is also the only generic technology that can provide data on
interactions mediated by speciﬁc post translational modiﬁcation
(PTM) such as phosphorylation in a close to in vivo situation [90–
92]. Our laboratory has recently used SILAC for the systematic
study of the phosphotyrosine interactome of the EGFR receptor
family as well as the insulin receptor family and its substrates
IRS-1 and IRS-2 [93,94]. Miller et al. combined bioinformatics ap-
proaches to ﬁrst decompose 481 unique tyrosine phosphopeptides
by sequence similarity to known ligands of SH2 and PTB domains
[26]. The partition around medoids (PAM) based clustering of these
phosphopeptides, which were transformed as vectors of 11 SH2
and PTB weight matrices led to four novel motifs (in addition to
16 known motifs). Subsequently, SILAC was employed to conﬁrm
15 novel phosphosite mediated interactions with SH2 or PTB. Rin-
ner et al analyzed protein complexes through the integration of la-
bel-free, quantitative mass spectrometry and computational
analysis [95]. Using this approach the authors identiﬁed known
and novel interactors of FoxO3A with 14-3-3 proteins.5. Data analysis, visualization and presentation in quantitative
proteomics
Bioinformatics tools and resources for genomics, functional
genomics, and structural genomics efforts are aplenty, and have a
large user and developer base. MS-based proteomics is a recent
member of the ‘omics’ clan and is starting to attract considerable
attention from the biomedical informatics community. Many of
the analysis algorithms and tools developed for functional genom-
ics are being leveraged in proteomics related bioinformatics appli-
cations. Most common among them are the tools for unsupervised
and supervised clustering and visualization. Hierarchical clustering
and k-means algorithm especially have found numerous applica-
tions in modern proteomics due to their simple algorithmic
assumptions, and intuitively clear and interpretable visualization
[96]. As complex proteomics data sets have started to be generated,
they require sophisticated analytical treatments and visualization
capabilities. With high dimensionality comes the need of statisti-
cally robust machine learning techniques [97] which are now
being applied in proteomics and statistical and graphical aspects
of these data sets are being explored. The R framework, which in
the past decade has emerged as the lingua franca for open source
statistical and machine learning research, has already permeated
the microarray community through its bioinformatics chapter
called Bioconductor [40,41]. We have adapted R and Bioconductor
for most of our proteo-bioinformatics analyses due to its expansive
capabilities in data mining, statistical procedures, and excellent
graphics. Moreover, R is open source; enables quick prototyping
and thereby delivers results faster without the need to reinvent
the wheel. We foresee that as bioinformatics for proteomics ma-
tures, R and Bioconductor will become an indispensable toolkit in
proteomics research. Additionally, proteomics will continue to
beneﬁt from experiences and challenges faced by the microarray
and related gene expression communities. This process, too, is
facilitated by an open, active and collaborative environment such
as R and Bioconductor embody.
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In this post-genomic era proteomics along with sister ‘omics’
disciplines provides the foundations on which the promise of sys-
tems biology will be realized. The next steps in this direction are
consolidation and integration of data sets and information across
different layers of the ‘omics’ hierarchy, ultimately leading to phys-
iologically accurate and clinically relevant in silico models of bio-
logical processes and systems. Future bioinformatics activities in
proteomics will increasingly focus on integrative systems biology,
as there are many aspects of cellular function which can only be
answered by adopting this approach. Currently, the challenges
one faces during such analyses involve seemingly mundane issues
such as the mapping of identiﬁed proteins to genomic and micro-
array identiﬁers. Due to many-to-many mapping between proteins
and their corresponding genes this problem is further com-
pounded. There are now frameworks like BioMart [98] which pro-
vide mapping from protein to genomic identiﬁers, but which still
harbor inconsistencies due to error propagation from legacy issues
during automated data integration. Biomedical research until re-
cently has been genomic oriented so most of the ontologies and
annotation databases are still ‘gene centric’, and often fail to cap-
ture protein speciﬁc characteristic and functions, which arise from
the greater diversity of proteins compared to genes. On a more ab-
stract level, it is clear that proteomics and other large-scale ‘post-
genomic’ technologies will proﬁt tremendously from further
investments into accurate and detailed Gene (or more accurately
Protein) Ontologies. Indeed, the more comprehensive such ontolo-
gies are, the easier it will be to infer function directly from quanti-
tative proteomics data sets.
Proteomics has ﬁnally started to attract the attention of key
stakeholders in bioinformatics database development process
and we envisage that in future these resources will be tuned to
the needs of proteomics research. More scientiﬁc investments are
required to generate uniﬁed and comprehensive proteomics data-
base along the lines of microarray databases and in this respect the
recent strong interest of the National Institutes of Health (NIH) in
addition the longstanding one of the European Bioinformatics
Institute (EBI) are positive factors. However, the key factor here
is how to control the accumulation of false positives, for example
in organellar databases. As mentioned above for genome annota-
tion, we envision that only extremely accurate proteomics data
sets, and not any data sets contributed by the proteomics commu-
nity, should be used for this purpose.
As proteomics is further integrated into the fabric of contempo-
rary biomedical ecosystem it will also become a key driver of bio-
informatics research. Although from the data structure and
analysis points of view parallels can be drawn with genomics
and transcriptomics data sets, proteomics data sets are still unique
in their constitution and underlying assumptions. Therefore, com-
plete exploitation and optimal harnessing of this uniqueness will
necessitate development of novel analytical and bioinformatics ap-
proaches. In due course proteomic related bioinformatics activities
will create its own identity and evolve as a new stream of biomed-
ical informatics research with exciting avenues.Acknowledgments
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